Loading
Chordia Therapeutics 株式会社 has a thin disclosure history in our data (latest filing: 10 March 2026). New filings will appear here as soon as they are published. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
7 of 7 declarations
Chordia Therapeutics is a Japanese company focused on developing innovative therapies. It operates on the Tokyo Stock Exchange under the symbol XTKS.